BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 22249405)

  • 1. HIV reservoirs and strategies for eradication.
    Smith MZ; Wightman F; Lewin SR
    Curr HIV/AIDS Rep; 2012 Mar; 9(1):5-15. PubMed ID: 22249405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV reservoirs: pathogenesis and obstacles to viral eradication and cure.
    Chun TW; Fauci AS
    AIDS; 2012 Jun; 26(10):1261-8. PubMed ID: 22472858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The search for a cure for persistent HIV reservoirs.
    Lafeuillade A; Stevenson M
    AIDS Rev; 2011; 13(2):63-6. PubMed ID: 21587339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of latency reversal agents in the cure of HIV: A review of current data.
    Bashiri K; Rezaei N; Nasi M; Cossarizza A
    Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Reservoirs During Suppressive Therapy.
    Barton K; Winckelmann A; Palmer S
    Trends Microbiol; 2016 May; 24(5):345-355. PubMed ID: 26875617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission Strategies.
    Delannoy A; Poirier M; Bell B
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30889861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VIP-SPOT: an Innovative Assay To Quantify the Productive HIV-1 Reservoir in the Monitoring of Cure Strategies.
    Puertas MC; Bayón-Gil Á; Garcia-Guerrero MC; Salgado M; Urrea V; Morón-López S; Peña R; Jiménez-Moyano E; Clotet B; Prado JG; Martinez-Picado J
    mBio; 2021 Jun; 12(3):e0056021. PubMed ID: 34154408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV reservoirs and the possibility of a cure for HIV infection.
    Palmer S; Josefsson L; Coffin JM
    J Intern Med; 2011 Dec; 270(6):550-60. PubMed ID: 21929712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finding a cure for HIV: will it ever be achievable?
    Lewin SR; Evans VA; Elliott JH; Spire B; Chomont N
    J Int AIDS Soc; 2011 Jan; 14():4. PubMed ID: 21255462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combating the HIV reservoirs.
    van Marle G; Church DL; van der Meer F; Gill MJ
    Biotechnol Genet Eng Rev; 2018 Apr; 34(1):76-89. PubMed ID: 29781356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mouse viral outgrowth assay: avatars for the detection of HIV-1 reservoirs.
    Metcalf Pate KA; Blankson JN
    Retrovirology; 2017 Nov; 14(1):52. PubMed ID: 29157283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
    Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
    J Virol; 2018 May; 92(9):. PubMed ID: 29444937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Models of HIV-1 persistence in the CD4+ T cell compartment: past, present and future.
    Tyagi M; Romerio F
    Curr HIV Res; 2011 Dec; 9(8):579-87. PubMed ID: 22211662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 reservoir dynamics in CD4+ T cells.
    Bruner KM; Cohn LB
    Curr Opin HIV AIDS; 2019 Mar; 14(2):108-114. PubMed ID: 30531293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From reactivation of latent HIV-1 to elimination of the latent reservoir: the presence of multiple barriers to viral eradication.
    Shan L; Siliciano RF
    Bioessays; 2013 Jun; 35(6):544-52. PubMed ID: 23613347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicle-mediated intercellular communication in HIV-1 infection and its role in the reservoir maintenance.
    Olivetta E; Chiozzini C; Arenaccio C; Manfredi F; Ferrantelli F; Federico M
    Cytokine Growth Factor Rev; 2020 Feb; 51():40-48. PubMed ID: 31926807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for measuring HIV reservoir size in cure-directed clinical trials.
    Abdel-Mohsen M; Richman D; Siliciano RF; Nussenzweig MC; Howell BJ; Martinez-Picado J; Chomont N; Bar KJ; Yu XG; Lichterfeld M; Alcami J; Hazuda D; Bushman F; Siliciano JD; Betts MR; Spivak AM; Planelles V; Hahn BH; Smith DM; Ho YC; Buzon MJ; Gaebler C; Paiardini M; Li Q; Estes JD; Hope TJ; Kostman J; Mounzer K; Caskey M; Fox L; Frank I; Riley JL; Tebas P; Montaner LJ;
    Nat Med; 2020 Sep; 26(9):1339-1350. PubMed ID: 32895573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attacking the HIV reservoir from the immune and viral perspective.
    Massanella M; Martinez-Picado J; Blanco J
    Curr HIV/AIDS Rep; 2013 Mar; 10(1):33-41. PubMed ID: 23242702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Eradication Strategies: Implications for the Central Nervous System.
    Veenhuis RT; Clements JE; Gama L
    Curr HIV/AIDS Rep; 2019 Feb; 16(1):96-104. PubMed ID: 30734905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1
    Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM
    J Virol; 2019 May; 93(10):. PubMed ID: 30842333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.